Searching for somatic mutations in McCune-Albright syndrome: A comparative study of the peptidic nucleic acid versus the nested PCR method based on 148 DNA samples

N. Kalfa, P. Philibert, F. Audran, A. Ecochard, Tamara Hannon, S. Lumbroso, C. Sultan

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: Activating mutations of the Gsα gene (GNAS), which encodes for the α-subunit of the stimulatory G protein, have been identified in patients with McCune-Albright syndrome (MAS). Accuracy and sensitivity in the molecular diagnosis of MAS is mandatory for optimal therapeutic strategy and adapted follow-up, especially for incomplete clinical forms of MAS. To date, the highly sensitive nested PCR method with intermediary digestion by a restriction enzyme at the mutation site is one of the most widely used techniques. This study evaluated a new diagnostic method using a peptidic nucleic acid (PNA) and compared it with the nested PCR method. Material and methods: One hundred and forty-eight DNA samples from eighty-eight patients presenting clinical symptoms compatible with MAS were included. The DNA samples were mainly obtained from peripheral blood, ovarian tissue or cyst liquid, and bone lesions. The nested PCR method required 4 days. PNA clamping required 1.5 days and utilized the higher thermal stability and specificity of PNA-DNA coupling to inhibit PCR product formation. Direct sequencing was subsequently performed in all cases. Results: The sensitivity of mutation detection was 54% (n = 80) for nested PCR and 46.6% (n = 69) for PNA (P > 0.0 5). The 11 cases where PNA failed to detect the mutation were mainly incomplete and atypical clinical forms of MAS (n = 10/11). The cost per sample was 50 euros for PNA clamping versus 136 euros for nested PCR. Conclusion: PNA clamping is a rapid, reliable, and economical method to diagnose MAS. It should be the first-line diagnostic method, althoug gative results, especially for incomplete clinical forms of MAS, should be confirmed by nested PCR.

Original languageEnglish
Pages (from-to)839-843
Number of pages5
JournalEuropean Journal of Endocrinology
Volume155
Issue number6
DOIs
StatePublished - Dec 2006

Fingerprint

Polyostotic Fibrous Dysplasia
Nucleic Acids
Polymerase Chain Reaction
Mutation
DNA
Constriction
Bone Cysts
GTP-Binding Proteins
Digestion
Hot Temperature
Costs and Cost Analysis
Enzymes

ASJC Scopus subject areas

  • Endocrinology

Cite this

Searching for somatic mutations in McCune-Albright syndrome : A comparative study of the peptidic nucleic acid versus the nested PCR method based on 148 DNA samples. / Kalfa, N.; Philibert, P.; Audran, F.; Ecochard, A.; Hannon, Tamara; Lumbroso, S.; Sultan, C.

In: European Journal of Endocrinology, Vol. 155, No. 6, 12.2006, p. 839-843.

Research output: Contribution to journalArticle

@article{9d316d06a4514a9086848c1e42801855,
title = "Searching for somatic mutations in McCune-Albright syndrome: A comparative study of the peptidic nucleic acid versus the nested PCR method based on 148 DNA samples",
abstract = "Background: Activating mutations of the Gsα gene (GNAS), which encodes for the α-subunit of the stimulatory G protein, have been identified in patients with McCune-Albright syndrome (MAS). Accuracy and sensitivity in the molecular diagnosis of MAS is mandatory for optimal therapeutic strategy and adapted follow-up, especially for incomplete clinical forms of MAS. To date, the highly sensitive nested PCR method with intermediary digestion by a restriction enzyme at the mutation site is one of the most widely used techniques. This study evaluated a new diagnostic method using a peptidic nucleic acid (PNA) and compared it with the nested PCR method. Material and methods: One hundred and forty-eight DNA samples from eighty-eight patients presenting clinical symptoms compatible with MAS were included. The DNA samples were mainly obtained from peripheral blood, ovarian tissue or cyst liquid, and bone lesions. The nested PCR method required 4 days. PNA clamping required 1.5 days and utilized the higher thermal stability and specificity of PNA-DNA coupling to inhibit PCR product formation. Direct sequencing was subsequently performed in all cases. Results: The sensitivity of mutation detection was 54{\%} (n = 80) for nested PCR and 46.6{\%} (n = 69) for PNA (P > 0.0 5). The 11 cases where PNA failed to detect the mutation were mainly incomplete and atypical clinical forms of MAS (n = 10/11). The cost per sample was 50 euros for PNA clamping versus 136 euros for nested PCR. Conclusion: PNA clamping is a rapid, reliable, and economical method to diagnose MAS. It should be the first-line diagnostic method, althoug gative results, especially for incomplete clinical forms of MAS, should be confirmed by nested PCR.",
author = "N. Kalfa and P. Philibert and F. Audran and A. Ecochard and Tamara Hannon and S. Lumbroso and C. Sultan",
year = "2006",
month = "12",
doi = "10.1530/eje.1.02301",
language = "English",
volume = "155",
pages = "839--843",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd.",
number = "6",

}

TY - JOUR

T1 - Searching for somatic mutations in McCune-Albright syndrome

T2 - A comparative study of the peptidic nucleic acid versus the nested PCR method based on 148 DNA samples

AU - Kalfa, N.

AU - Philibert, P.

AU - Audran, F.

AU - Ecochard, A.

AU - Hannon, Tamara

AU - Lumbroso, S.

AU - Sultan, C.

PY - 2006/12

Y1 - 2006/12

N2 - Background: Activating mutations of the Gsα gene (GNAS), which encodes for the α-subunit of the stimulatory G protein, have been identified in patients with McCune-Albright syndrome (MAS). Accuracy and sensitivity in the molecular diagnosis of MAS is mandatory for optimal therapeutic strategy and adapted follow-up, especially for incomplete clinical forms of MAS. To date, the highly sensitive nested PCR method with intermediary digestion by a restriction enzyme at the mutation site is one of the most widely used techniques. This study evaluated a new diagnostic method using a peptidic nucleic acid (PNA) and compared it with the nested PCR method. Material and methods: One hundred and forty-eight DNA samples from eighty-eight patients presenting clinical symptoms compatible with MAS were included. The DNA samples were mainly obtained from peripheral blood, ovarian tissue or cyst liquid, and bone lesions. The nested PCR method required 4 days. PNA clamping required 1.5 days and utilized the higher thermal stability and specificity of PNA-DNA coupling to inhibit PCR product formation. Direct sequencing was subsequently performed in all cases. Results: The sensitivity of mutation detection was 54% (n = 80) for nested PCR and 46.6% (n = 69) for PNA (P > 0.0 5). The 11 cases where PNA failed to detect the mutation were mainly incomplete and atypical clinical forms of MAS (n = 10/11). The cost per sample was 50 euros for PNA clamping versus 136 euros for nested PCR. Conclusion: PNA clamping is a rapid, reliable, and economical method to diagnose MAS. It should be the first-line diagnostic method, althoug gative results, especially for incomplete clinical forms of MAS, should be confirmed by nested PCR.

AB - Background: Activating mutations of the Gsα gene (GNAS), which encodes for the α-subunit of the stimulatory G protein, have been identified in patients with McCune-Albright syndrome (MAS). Accuracy and sensitivity in the molecular diagnosis of MAS is mandatory for optimal therapeutic strategy and adapted follow-up, especially for incomplete clinical forms of MAS. To date, the highly sensitive nested PCR method with intermediary digestion by a restriction enzyme at the mutation site is one of the most widely used techniques. This study evaluated a new diagnostic method using a peptidic nucleic acid (PNA) and compared it with the nested PCR method. Material and methods: One hundred and forty-eight DNA samples from eighty-eight patients presenting clinical symptoms compatible with MAS were included. The DNA samples were mainly obtained from peripheral blood, ovarian tissue or cyst liquid, and bone lesions. The nested PCR method required 4 days. PNA clamping required 1.5 days and utilized the higher thermal stability and specificity of PNA-DNA coupling to inhibit PCR product formation. Direct sequencing was subsequently performed in all cases. Results: The sensitivity of mutation detection was 54% (n = 80) for nested PCR and 46.6% (n = 69) for PNA (P > 0.0 5). The 11 cases where PNA failed to detect the mutation were mainly incomplete and atypical clinical forms of MAS (n = 10/11). The cost per sample was 50 euros for PNA clamping versus 136 euros for nested PCR. Conclusion: PNA clamping is a rapid, reliable, and economical method to diagnose MAS. It should be the first-line diagnostic method, althoug gative results, especially for incomplete clinical forms of MAS, should be confirmed by nested PCR.

UR - http://www.scopus.com/inward/record.url?scp=33845966717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845966717&partnerID=8YFLogxK

U2 - 10.1530/eje.1.02301

DO - 10.1530/eje.1.02301

M3 - Article

C2 - 17132753

AN - SCOPUS:33845966717

VL - 155

SP - 839

EP - 843

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

IS - 6

ER -